相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification and characterization of peripheral vascular color-coded DECT lesions in gout and non-gout patients: The VASCURATE study
Tristan Pascart et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2021)
Discontinuing febuxostat might cause more deaths than continuing febuxostat: the untold story from the CARES trial
Byeongzu Ghang et al.
RHEUMATOLOGY (2020)
Colchicine in Patients with Chronic Coronary Disease
Stefan M. Nidorf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial
Isla S. Mackenzie et al.
LANCET (2020)
Quantification of uric acid in vasculature of patients with gout using dual-energy computed tomography
Sharon Hannah Barazani et al.
WORLD JOURNAL OF RADIOLOGY (2020)
CARDIOVASCULAR EVENT ASSOCIATED WITH INITIATING ALLOPURINOL AND FEBUXOSTAT - ACUTE GOUT ATTACK AND CARDIOVASCULAR GOUT ATTACK
H. J. Kim et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Comparative cardiovascular risk of allopurinol versus febuxostat in patients with gout: a nation-wide cohort study
Eun Ha Kang et al.
RHEUMATOLOGY (2019)
Dual-Energy Computed Tomography Detection of Cardiovascular Monosodium Urate Deposits in Patients With Gout
Andrea Sabine Klauser et al.
JAMA CARDIOLOGY (2019)
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean-Claude Tardif et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study
MaryAnn Zhang et al.
CIRCULATION (2018)
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
William B. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Implications of the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities Trial and the Associated Food and Drug Administration Public Safety Alert
Hyon Choi et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Inflammation and plaque vulnerability
G. K. Hansson et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Non-adherence to cardiovascular medications
Kumaran Kolandaivelu et al.
EUROPEAN HEART JOURNAL (2014)
Prevalence of birefringent crystals in cardiac and prostatic tissues, an observational study
Jane J. Park et al.
BMJ OPEN (2014)
The urate-lowering Efficacy and Safety of Febuxostat in the Treatment Hyperuricemia of Gout: The CONFIRMS trial
C. Dejaco et al.
JOURNAL FUR MINERALSTOFFWECHSEL (2010)
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Michael A. Becker et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study
H. R. Schumacher et al.
RHEUMATOLOGY (2009)
Adherence to lipid-lowering therapy and the use of preventive health services: An investigation of the healthy user effect
M. Alan Brookhart et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Febuxostat compared with allopurinol in patients with hyperuricemia and gout
MA Becker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease
GK Hansson
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
